跳至主要内容
临床试验/NCT07353125
NCT07353125已完成不适用

Evaluation of the Blood Glucose Monitoring System LS-9 of Leison Biotech Co., Ltd. in Accordance With DIN EN ISO 15197:2015

Institut fur Diabetes Karlsburg GmbH0 个研究点目标入组 219 人开始时间: 2025年7月21日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
219

研究概览

简要总结

This study assesses the system accuracy and performance evaluation by the user of a blood glucose monitoring system pursuant to ISO 15197

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female patients with hypo-, eu- or hyperglycaemia
  • The written informed consent had to be signed
  • The volunteers must be older than 18 years
  • The volunteers have legal capacity and are able to understand meaning, nature and possible consequences of the procedures involved

排除标准

  • Pregnancy or lactation
  • Acute or chronic diseases with the risk of aggravation by the measure
  • A current constitution that does not allow participating in the study
  • Participation in another study or activity with the blood glucose measuring system evaluated in the present study
  • Application of substances listed in Appendix A of DIN EN ISO 15197:2015

研究者

发起方
Institut fur Diabetes Karlsburg GmbH
申办方类型
Other
责任方
Principal Investigator
主要研究者

Matthes Kenning

Eckhard Salzsieder, Principal Investigator

Institut fur Diabetes Karlsburg GmbH

相似试验